THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
174,027,984
Share change
+13,132,967
Total reported value
$233,195,315
Put/Call ratio
95%
Price per share
$1.34
Number of holders
154
Value change
+$19,299,909
Number of buys
85
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2021

As of 31 Mar 2021, THERAPEUTICSMD INC - COM (TXMD) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 174,027,984 shares. The largest 10 holders included BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FMR LLC, RA CAPITAL MANAGEMENT, L.P., MORGAN STANLEY, STATE STREET CORP, AXA S.A., C WorldWide Group Holding A/S, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 154 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.